Basic and Clinical Sciences (BCSE) Practice Exam

Weight loss is not considered a common treatment for pulmonary hypertension, even though maintaining a healthy weight can be beneficial for overall health. The primary management strategies for pulmonary hypertension focus on directly addressing the underlying pathophysiology and improving hemodynamics within the pulmonary circulation.

Anticoagulation is commonly utilized, particularly in patients with pulmonary embolism contributing to their condition. It helps prevent further clot formation and manage existing clots. Diuretics are also frequently employed to alleviate symptoms related to fluid overload, which can occur in congestive heart failure, a common cause of pulmonary hypertension. Lastly, vasodilators play a critical role in the management of pulmonary hypertension by directly relaxing the pulmonary blood vessels, improving blood flow and reducing the pressure in the pulmonary arteries.

While weight loss may be beneficial as a general health recommendation and in some cases of obesity-related respiratory issues, it is not a primary or standard treatment specifically for pulmonary hypertension.